The Latest Breaking News from Achieve

Achieve Life Sciences Inc. (NASDAQ:ACHV) is moving closer to a pivotal moment as it seeks FDA approval for cytisinicline, a potential first new smoking cessation therapy in nearly two decades, positioning the company for a high-stakes commercial launch in 2026.

For Women's History Month, we're highlighting a new study that shows how women are increasing their financial independence, despite the struggles they face.

Alison McGuinness has applied for regulator’s approval of Bolton facility using new company with different name

AS the curtain came down on Birmingham 2022 Commonwealth Games, those on the Team Scotland Achieve programme were treated to one more sporting…